US Stock MarketDetailed Quotes

PYXS Pyxis Oncology

Watchlist
  • 2.100
  • -1.720-45.03%
Close Nov 21 16:00 ET
  • 2.080
  • -0.020-0.95%
Pre 08:43 ET
124.88MMarket Cap-1981P/E (TTM)

Pyxis Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.60%-14.67M
72.74%-3.01M
22.84%-20.71M
20.85%-70.71M
12.27%-15.25M
14.47%-17.58M
53.48%-11.03M
3.03%-26.84M
-152.89%-89.34M
-42.88%-17.39M
Net income from continuing operations
8.01%-21.2M
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
Depreciation and amortization
39.77%731K
11.64%585K
487.37%1.12M
171.79%1.93M
259.38%690K
161.50%523K
229.56%524K
20.25%190K
9.58%709K
21.52%192K
Other non cash items
16.23%179K
-2.29%171K
13.89%164K
-93.66%660K
-98.04%187K
-49.84%154K
-44.62%175K
-37.93%144K
-49.49%10.41M
6,023.72%9.55M
Change In working capital
294.40%4.3M
597.84%12.3M
-78.28%-21.77M
-359.14%-11.66M
-145.51%-2.31M
-49.56%1.09M
166.83%1.76M
-13,027.96%-12.21M
-32.58%4.5M
515.41%5.07M
-Change in receivables
----
----
---8M
----
----
----
----
--0
----
----
-Change in prepaid assets
22.24%1.26M
961.46%2.04M
-520.99%-2.05M
174.89%2.53M
126.89%820K
200.39%1.03M
-79.35%192K
309.48%486K
-38.34%-3.38M
-89.61%-3.05M
-Change in payables and accrued expense
504.57%3.37M
318.55%2.37M
74.99%-3.51M
-585.90%-17.6M
-174.76%-3.31M
-129.50%-832K
113.25%566K
-2,277.95%-14.03M
-62.78%3.62M
-25.68%4.43M
-Change in other current liabilities
-191.69%-331K
-110.35%-104K
-141.47%-552K
-43.41%2.41M
-107.78%-287K
-2.70%361K
176.86%1.01M
906.67%1.33M
792.52%4.26M
204.56%3.69M
-Change in other working capital
--0
--0
---7.66M
--998K
--471K
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
16.60%-14.67M
72.74%-3.01M
22.84%-20.71M
20.85%-70.71M
12.27%-15.25M
14.47%-17.58M
53.48%-11.03M
3.03%-26.84M
-152.89%-89.34M
-42.88%-17.39M
Investing cash flow
Cash flow from continuing investing activities
-100.12%-8K
100.02%4K
81.39%-18.5M
-1,538.52%-104.85M
650.48%10.23M
254.03%6.57M
-17,151.94%-22.26M
-67,977.40%-99.39M
-984.58%-6.4M
-1.86M
Net PPE purchase and sale
--0
--0
94.62%-237K
-5.11%-6.73M
--0
98.57%-61K
-1,651.16%-2.26M
-2,917.81%-4.41M
-1,085.00%-6.4M
---1.86M
Net business purchase and sale
----
----
----
--6.66M
--1K
----
----
----
--0
--0
Net investment purchase and sale
70.37%-8K
100.02%4K
80.78%-18.26M
---104.78M
--10.23M
---27K
---20M
---94.99M
--0
--0
Cash from discontinued investing activities
Investing cash flow
-100.12%-8K
100.02%4K
81.39%-18.5M
-1,538.52%-104.85M
650.48%10.23M
254.03%6.57M
-17,151.94%-22.26M
-67,977.40%-99.39M
-984.58%-6.4M
---1.86M
Financing cash flow
Cash flow from continuing financing activities
1,067.84%1.66M
-98.20%110K
57.51M
3,139.89%5.93M
-25K
-2,950.00%-171K
612,400.00%6.13M
0
-99.94%183K
0
Net common stock issuance
--1.58M
--0
--57.46M
--6.12M
--0
--0
--6.12M
--0
--0
--0
Proceeds from stock option exercised by employees
-67.57%72K
5,000.00%153K
--245K
37.70%252K
--27K
3,600.00%222K
200.00%3K
--0
9.58%183K
--0
Net other financing activities
---1K
---43K
---196K
---445K
---52K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,067.84%1.66M
-98.20%110K
--57.51M
3,139.89%5.93M
---25K
-2,950.00%-171K
612,400.00%6.13M
--0
-99.94%183K
--0
Net cash flow
Beginning cash position
-3.01%26.55M
-46.01%29.44M
-93.84%11.14M
-34.58%180.77M
-91.91%16.19M
-87.83%27.37M
-78.07%54.53M
-34.58%180.77M
3,274.65%276.32M
49.72%200.01M
Current changes in cash
-16.41%-13.02M
89.35%-2.89M
114.50%18.3M
-77.53%-169.63M
73.75%-5.05M
54.94%-11.18M
-13.93%-27.16M
-356.56%-126.23M
-135.64%-95.55M
-113.48%-19.25M
End cash Position
-16.43%13.53M
-3.01%26.55M
-46.01%29.44M
-93.84%11.14M
-93.84%11.14M
-91.91%16.19M
-87.83%27.37M
-78.07%54.53M
-34.58%180.77M
-34.58%180.77M
Free cash flow
16.88%-14.67M
77.37%-3.01M
32.96%-20.95M
19.11%-77.44M
20.74%-15.25M
28.92%-17.64M
44.26%-13.29M
-12.30%-31.25M
-166.92%-95.73M
-58.15%-19.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.60%-14.67M72.74%-3.01M22.84%-20.71M20.85%-70.71M12.27%-15.25M14.47%-17.58M53.48%-11.03M3.03%-26.84M-152.89%-89.34M-42.88%-17.39M
Net income from continuing operations 8.01%-21.2M-8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M
Depreciation and amortization 39.77%731K11.64%585K487.37%1.12M171.79%1.93M259.38%690K161.50%523K229.56%524K20.25%190K9.58%709K21.52%192K
Other non cash items 16.23%179K-2.29%171K13.89%164K-93.66%660K-98.04%187K-49.84%154K-44.62%175K-37.93%144K-49.49%10.41M6,023.72%9.55M
Change In working capital 294.40%4.3M597.84%12.3M-78.28%-21.77M-359.14%-11.66M-145.51%-2.31M-49.56%1.09M166.83%1.76M-13,027.96%-12.21M-32.58%4.5M515.41%5.07M
-Change in receivables -----------8M------------------0--------
-Change in prepaid assets 22.24%1.26M961.46%2.04M-520.99%-2.05M174.89%2.53M126.89%820K200.39%1.03M-79.35%192K309.48%486K-38.34%-3.38M-89.61%-3.05M
-Change in payables and accrued expense 504.57%3.37M318.55%2.37M74.99%-3.51M-585.90%-17.6M-174.76%-3.31M-129.50%-832K113.25%566K-2,277.95%-14.03M-62.78%3.62M-25.68%4.43M
-Change in other current liabilities -191.69%-331K-110.35%-104K-141.47%-552K-43.41%2.41M-107.78%-287K-2.70%361K176.86%1.01M906.67%1.33M792.52%4.26M204.56%3.69M
-Change in other working capital --0--0---7.66M--998K--471K--------------------
Cash from discontinued investing activities
Operating cash flow 16.60%-14.67M72.74%-3.01M22.84%-20.71M20.85%-70.71M12.27%-15.25M14.47%-17.58M53.48%-11.03M3.03%-26.84M-152.89%-89.34M-42.88%-17.39M
Investing cash flow
Cash flow from continuing investing activities -100.12%-8K100.02%4K81.39%-18.5M-1,538.52%-104.85M650.48%10.23M254.03%6.57M-17,151.94%-22.26M-67,977.40%-99.39M-984.58%-6.4M-1.86M
Net PPE purchase and sale --0--094.62%-237K-5.11%-6.73M--098.57%-61K-1,651.16%-2.26M-2,917.81%-4.41M-1,085.00%-6.4M---1.86M
Net business purchase and sale --------------6.66M--1K--------------0--0
Net investment purchase and sale 70.37%-8K100.02%4K80.78%-18.26M---104.78M--10.23M---27K---20M---94.99M--0--0
Cash from discontinued investing activities
Investing cash flow -100.12%-8K100.02%4K81.39%-18.5M-1,538.52%-104.85M650.48%10.23M254.03%6.57M-17,151.94%-22.26M-67,977.40%-99.39M-984.58%-6.4M---1.86M
Financing cash flow
Cash flow from continuing financing activities 1,067.84%1.66M-98.20%110K57.51M3,139.89%5.93M-25K-2,950.00%-171K612,400.00%6.13M0-99.94%183K0
Net common stock issuance --1.58M--0--57.46M--6.12M--0--0--6.12M--0--0--0
Proceeds from stock option exercised by employees -67.57%72K5,000.00%153K--245K37.70%252K--27K3,600.00%222K200.00%3K--09.58%183K--0
Net other financing activities ---1K---43K---196K---445K---52K--------------------
Cash from discontinued financing activities
Financing cash flow 1,067.84%1.66M-98.20%110K--57.51M3,139.89%5.93M---25K-2,950.00%-171K612,400.00%6.13M--0-99.94%183K--0
Net cash flow
Beginning cash position -3.01%26.55M-46.01%29.44M-93.84%11.14M-34.58%180.77M-91.91%16.19M-87.83%27.37M-78.07%54.53M-34.58%180.77M3,274.65%276.32M49.72%200.01M
Current changes in cash -16.41%-13.02M89.35%-2.89M114.50%18.3M-77.53%-169.63M73.75%-5.05M54.94%-11.18M-13.93%-27.16M-356.56%-126.23M-135.64%-95.55M-113.48%-19.25M
End cash Position -16.43%13.53M-3.01%26.55M-46.01%29.44M-93.84%11.14M-93.84%11.14M-91.91%16.19M-87.83%27.37M-78.07%54.53M-34.58%180.77M-34.58%180.77M
Free cash flow 16.88%-14.67M77.37%-3.01M32.96%-20.95M19.11%-77.44M20.74%-15.25M28.92%-17.64M44.26%-13.29M-12.30%-31.25M-166.92%-95.73M-58.15%-19.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data